Eli Lilly Commits $12.5 Million to Cancer Research

Strategic Insights -

Eli Lilly and Co. has taken a substantial step towards advancing cancer research by committing $12.5 million to the Damon Runyon Cancer Research Foundation. This significant contribution aims to accelerate the pace and progress of cancer research in the United States. According to an American Cancer Society report, cancer has now become the leading cause of death in Americans under the age of 85. The alarming decline of trained physician-scientists pursuing clinical research has prompted Eli Lilly to take action and support the development of future researchers.

Key Takeaways:

  • Eli Lilly has committed $12.5 million to the Damon Runyon Cancer Research Foundation to support cancer research and development.
  • The contribution aims to address the alarming decline of trained physician-scientists pursuing clinical research, which has dropped significantly over the past 2 decades.
  • The number of physicians engaged in clinical research has decreased, leaving a significant gap in the development of future researchers who can find answers for patients.
  • The Clinical Investigator Award, supported by Eli Lilly, selects 5 young awardees each year, providing a 5-year $1 million grant, up to $100,000 in medical school debt relief, an annual salary, research funding, and mentorship support.
  • The award enables junior physicians to devote 80% of their time to research, compared to 10-20% in patient practice.
  • The Damon Runyon Cancer Research Foundation's Chairman of the Board, Dale F. Frey, has highlighted the issue of overwhelming debt from medical school as a significant barrier to young physicians pursuing careers in clinical research.
  • Richard Gaynor, MD, Vice President of Cancer Research at Eli Lilly, has emphasized the need for trained physician-scientists to tackle the growing health problem of cancer.

Statistics:

  • $12.5 million: Eli Lilly's contribution to the Damon Runyon Cancer Research Foundation.
  • 5 years: The duration of the Clinical Investigator Award.
  • $1 million: The annual grant provided to each of the 5 awardees.
  • $100,000: The amount of medical school debt relief provided to each awardee.
  • 80%: The percentage of time allocated to research for junior physicians under the Clinical Investigator Award.
  • 10-20%: The percentage of time allocated to research for junior physicians in patient practice.

Sources:

  • NewsRx.com
  • Health & Medicine Week, 2005